Selected research
Industry Growth & Trends
Global Urine Drug Testing Service Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Urine Drug Testing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Urine Drug Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Urine Drug Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Urine Drug Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Urine Drug Testing Service market include Abbott, Labcorp, Quest Diagnostics, Millennium Health, Genesis Reference Labs, Concentra, DISA, Medigold Health and Keystone Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Urine Drug Testing Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Urine Drug Testing Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Urine Drug Testing Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Urine Drug Testing Service.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Urine Drug Testing Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Urine Drug Testing Service Market by Company
Abbott
Labcorp
Quest Diagnostics
Millennium Health
Genesis Reference Labs
Concentra
DISA
Medigold Health
Keystone Laboratories
Crystal Health
MedTox
Australian Clinical Labs
Dominion Diagnostics
Matrix Diagnostics
Dorevitch Pathology
Urine Drug Testing Service Segment by Type
On-site Testing
Laboratory-based Testing
Urine Drug Testing Service Segment by Application
Hospital
Clinic
Others
Urine Drug Testing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Urine Drug Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Urine Drug Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Urine Drug Testing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Urine Drug Testing Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- On-site Testing
- Laboratory-based Testing
Applications
- Hospital
- Clinic
- Others
Companies covered
- Abbott
- Labcorp
- Quest Diagnostics
- Millennium Health
- Genesis Reference Labs
- Concentra
- DISA
- Medigold Health
- Keystone Laboratories
- Crystal Health
- MedTox
- Australian Clinical Labs
- Dominion Diagnostics
- Matrix Diagnostics
- Dorevitch Pathology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Urine Drug Testing Service Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Urine Drug Testing Service Market Size by Region (2021-2032)
- 1.4.1 Global Urine Drug Testing Service Market Size by Region (2021-2026)
- 1.4.2 Global Urine Drug Testing Service Market Size by Region (2027-2032)
- 1.5 Key Regions Urine Drug Testing Service Market Size (2021-2032)
- 1.5.1 North America Urine Drug Testing Service Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Urine Drug Testing Service Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Urine Drug Testing Service Market Size Growth Rate (2021-2032)
- 1.5.4 South America Urine Drug Testing Service Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Urine Drug Testing Service Market Size Growth Rate (2021-2032)
2 Urine Drug Testing Service Market by Type
- 2.1 Type Introduction
- 2.1.1 On-site Testing
- 2.1.2 Laboratory-based Testing
- 2.2 Global Urine Drug Testing Service Market Size by Type
- 2.2.1 Global Urine Drug Testing Service Market Size Overview by Type (2021-2032)
- 2.2.2 Global Urine Drug Testing Service Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Urine Drug Testing Service Market Size Forecasted by Type (2027-2032)
- 2.3 Global Urine Drug Testing Service Market Size by Regions
- 2.3.1 North America Urine Drug Testing Service Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Urine Drug Testing Service Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Urine Drug Testing Service Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Urine Drug Testing Service Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Urine Drug Testing Service Market Size Breakdown by Type (2021-2026)
3 Urine Drug Testing Service Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital
- 3.1.2 Clinic
- 3.1.3 Others
- 3.2 Global Urine Drug Testing Service Market Size by Application
- 3.2.1 Global Urine Drug Testing Service Market Size Overview by Application (2021-2032)
- 3.2.2 Global Urine Drug Testing Service Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Urine Drug Testing Service Market Size Forecasted by Application (2027-2032)
- 3.3 Global Urine Drug Testing Service Market Size by Regions
- 3.3.1 North America Urine Drug Testing Service Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Urine Drug Testing Service Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Urine Drug Testing Service Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Urine Drug Testing Service Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Urine Drug Testing Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Urine Drug Testing Service Industry Trends
- 4.2 Urine Drug Testing Service Industry Drivers
- 4.3 Urine Drug Testing Service Industry Opportunities and Challenges
- 4.4 Urine Drug Testing Service Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Urine Drug Testing Service Revenue (2021-2026)
- 5.2 Global Urine Drug Testing Service Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Urine Drug Testing Service Key Company Headquarters & Area Served
- 5.4 Global Urine Drug Testing Service Company, Product Type & Application
- 5.5 Global Urine Drug Testing Service Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Urine Drug Testing Service Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Urine Drug Testing Service Players Market Share by Revenue in 2025
- 5.6.3 2025 Urine Drug Testing Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Abbott
- 6.1.1 Abbott Company Information
- 6.1.2 Abbott Business Overview
- 6.1.3 Abbott Urine Drug Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Abbott Urine Drug Testing Service Product Portfolio
- 6.1.5 Abbott Recent Developments
- 6.2 Labcorp
- 6.2.1 Labcorp Company Information
- 6.2.2 Labcorp Business Overview
- 6.2.3 Labcorp Urine Drug Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Labcorp Urine Drug Testing Service Product Portfolio
- 6.2.5 Labcorp Recent Developments
- 6.3 Quest Diagnostics
- 6.3.1 Quest Diagnostics Company Information
- 6.3.2 Quest Diagnostics Business Overview
- 6.3.3 Quest Diagnostics Urine Drug Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Quest Diagnostics Urine Drug Testing Service Product Portfolio
- 6.3.5 Quest Diagnostics Recent Developments
- 6.4 Millennium Health
- 6.4.1 Millennium Health Company Information
- 6.4.2 Millennium Health Business Overview
- 6.4.3 Millennium Health Urine Drug Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Millennium Health Urine Drug Testing Service Product Portfolio
- 6.4.5 Millennium Health Recent Developments
- 6.5 Genesis Reference Labs
- 6.5.1 Genesis Reference Labs Company Information
- 6.5.2 Genesis Reference Labs Business Overview
- 6.5.3 Genesis Reference Labs Urine Drug Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Genesis Reference Labs Urine Drug Testing Service Product Portfolio
- 6.5.5 Genesis Reference Labs Recent Developments
- 6.6 Concentra
- 6.6.1 Concentra Company Information
- 6.6.2 Concentra Business Overview
- 6.6.3 Concentra Urine Drug Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Concentra Urine Drug Testing Service Product Portfolio
- 6.6.5 Concentra Recent Developments
- 6.7 DISA
- 6.7.1 DISA Company Information
- 6.7.2 DISA Business Overview
- 6.7.3 DISA Urine Drug Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 DISA Urine Drug Testing Service Product Portfolio
- 6.7.5 DISA Recent Developments
- 6.8 Medigold Health
- 6.8.1 Medigold Health Company Information
- 6.8.2 Medigold Health Business Overview
- 6.8.3 Medigold Health Urine Drug Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Medigold Health Urine Drug Testing Service Product Portfolio
- 6.8.5 Medigold Health Recent Developments
- 6.9 Keystone Laboratories
- 6.9.1 Keystone Laboratories Company Information
- 6.9.2 Keystone Laboratories Business Overview
- 6.9.3 Keystone Laboratories Urine Drug Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Keystone Laboratories Urine Drug Testing Service Product Portfolio
- 6.9.5 Keystone Laboratories Recent Developments
- 6.10 Crystal Health
- 6.10.1 Crystal Health Company Information
- 6.10.2 Crystal Health Business Overview
- 6.10.3 Crystal Health Urine Drug Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Crystal Health Urine Drug Testing Service Product Portfolio
- 6.10.5 Crystal Health Recent Developments
- 6.11 MedTox
- 6.11.1 MedTox Company Information
- 6.11.2 MedTox Business Overview
- 6.11.3 MedTox Urine Drug Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 MedTox Urine Drug Testing Service Product Portfolio
- 6.11.5 MedTox Recent Developments
- 6.12 Australian Clinical Labs
- 6.12.1 Australian Clinical Labs Company Information
- 6.12.2 Australian Clinical Labs Business Overview
- 6.12.3 Australian Clinical Labs Urine Drug Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Australian Clinical Labs Urine Drug Testing Service Product Portfolio
- 6.12.5 Australian Clinical Labs Recent Developments
- 6.13 Dominion Diagnostics
- 6.13.1 Dominion Diagnostics Company Information
- 6.13.2 Dominion Diagnostics Business Overview
- 6.13.3 Dominion Diagnostics Urine Drug Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Dominion Diagnostics Urine Drug Testing Service Product Portfolio
- 6.13.5 Dominion Diagnostics Recent Developments
- 6.14 Matrix Diagnostics
- 6.14.1 Matrix Diagnostics Company Information
- 6.14.2 Matrix Diagnostics Business Overview
- 6.14.3 Matrix Diagnostics Urine Drug Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Matrix Diagnostics Urine Drug Testing Service Product Portfolio
- 6.14.5 Matrix Diagnostics Recent Developments
- 6.15 Dorevitch Pathology
- 6.15.1 Dorevitch Pathology Company Information
- 6.15.2 Dorevitch Pathology Business Overview
- 6.15.3 Dorevitch Pathology Urine Drug Testing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Dorevitch Pathology Urine Drug Testing Service Product Portfolio
- 6.15.5 Dorevitch Pathology Recent Developments
7 North America
- 7.1 North America Urine Drug Testing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Urine Drug Testing Service Market Size by Country (2021-2026)
- 7.3 North America Urine Drug Testing Service Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Urine Drug Testing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Urine Drug Testing Service Market Size by Country (2021-2026)
- 8.3 Europe Urine Drug Testing Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Urine Drug Testing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Urine Drug Testing Service Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Urine Drug Testing Service Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Urine Drug Testing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Urine Drug Testing Service Market Size by Country (2021-2026)
- 10.3 South America Urine Drug Testing Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Urine Drug Testing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Urine Drug Testing Service Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Urine Drug Testing Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst